Rivaroxaban for oral suspension, 1 mg/ml (RLD Xarelto) had a market value of roughly $11 million, per IQVIA July 2025 data. Lupin has received approval from the Food and Drug Administration for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback